Valuation Viatris Inc. Wiener Boerse

Stocks

End-of-day quote Wiener Boerse 2026-10-02			5-day change	1st Jan Change
15.46 ^EUR	-1.63%		+1.22%	+47.20%

09-28	Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance	MT
09-28	Mylan seeks to clear patent obstacle for generic Wegovy	FW

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16,363	13,497	12,992	14,860	14,340	20,215	-	-
Change	-	-17.51%	-3.74%	14.38%	-3.5%	40.98%	-	-
Enterprise Value (EV) ¹	38,749	13,497	30,132	28,173	27,431	32,166	30,900	30,063
Change	-	-65.17%	123.25%	-6.5%	-2.63%	17.26%	-3.94%	-2.71%
P/E	-12.9x	6.51x	217x	-23.5x	-4.15x	75.7x	43.3x	32.4x
PBR	0.8x	-	0.64x	0.8x	0.97x	1.39x	1.34x	1.24x
PEG	-	-0x	-2.2x	0x	-0x	-1x	0.6x	1x
Capitalization / Revenue	0.91x	0.83x	0.84x	1.01x	1x	1.37x	1.34x	1.3x
EV / Revenue	2.17x	0.83x	1.95x	1.91x	1.92x	2.18x	2.05x	1.94x
EV / EBITDA	6.03x	2.34x	5.88x	6.03x	6.59x	7.25x	6.75x	6.23x
EV / EBIT	6.41x	2.47x	6.38x	6.67x	7.3x	7.94x	7.27x	6.64x
EV / FCF	15.1x	-	12.4x	14.3x	14.2x	15.2x	13.5x	19x
FCF Yield	6.61%	-	8.04%	7.02%	7.06%	6.58%	7.43%	5.28%
Dividend per Share ²	0.33	-	0.48	0.48	0.48	0.5088	0.5219	0.5056
Rate of return	2.44%	-	4.43%	3.86%	3.86%	2.89%	2.97%	2.87%
EPS ²	-1.05	1.71	0.05	-0.53	-3	0.2324	0.4062	0.544
Distribution rate	-31.4%	-	960%	-90.6%	-16%	219%	128%	93%
Net sales ¹	17,886	16,263	15,427	14,739	14,300	14,789	15,037	15,495
EBITDA ¹	6,426	5,777	5,124	4,669	4,160	4,436	4,581	4,827
EBIT ¹	6,046	5,475	4,724	4,225	3,759	4,052	4,253	4,530
Net income ¹	-1,269	2,079	54.7	-634.2	-3,515	141.5	298.4	624.6
Net Debt ¹	22,386	-	17,140	13,312	13,092	11,951	10,684	9,847
Reference price ²	13.53	11.13	10.83	12.45	12.45	17.60	17.60	17.60
Nbr of stocks (in thousands)	1,209,393	1,212,685	1,199,671	1,193,593	1,151,770	1,148,591	-	-
Announcement Date	2/28/22	2/27/23	2/28/24	2/27/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.74x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.28x	2.29%	410.8B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%